KR960001819B1 - Viral vector coding for a glycoprotein of the virus responsible - Google Patents

Viral vector coding for a glycoprotein of the virus responsible Download PDF

Info

Publication number
KR960001819B1
KR960001819B1 KR87701159A KR870701159A KR960001819B1 KR 960001819 B1 KR960001819 B1 KR 960001819B1 KR 87701159 A KR87701159 A KR 87701159A KR 870701159 A KR870701159 A KR 870701159A KR 960001819 B1 KR960001819 B1 KR 960001819B1
Authority
KR
South Korea
Prior art keywords
glycoprotein
viral vector
vector coding
virus responsible
virus
Prior art date
Application number
KR87701159A
Other languages
English (en)
Other versions
KR880701283A (ko
Inventor
Marie Paule Kieny
Guy Rautmann
Jean Pierre Lecocq
Simon Wain-Hobson
Marc Girard
Luc Montagnier
Original Assignee
Transgene Sa
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26225146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR960001819(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8605043A external-priority patent/FR2596771B1/fr
Application filed by Transgene Sa, Pasteur Institut filed Critical Transgene Sa
Publication of KR880701283A publication Critical patent/KR880701283A/ko
Application granted granted Critical
Publication of KR960001819B1 publication Critical patent/KR960001819B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR87701159A 1986-04-08 1987-12-08 Viral vector coding for a glycoprotein of the virus responsible KR960001819B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR8605043 1986-04-08
FR8605043A FR2596771B1 (fr) 1986-04-08 1986-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
FR8615106 1986-10-29
FR8615106A FR2606029B2 (fr) 1986-04-08 1986-10-29 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
PCT/FR1987/000116 WO1987006260A1 (fr) 1986-04-08 1987-04-08 Vecteur viral, codant pour une glycoproteine du virus responsable du s.i.d.a., vaccin et anticorps

Publications (2)

Publication Number Publication Date
KR880701283A KR880701283A (ko) 1988-07-26
KR960001819B1 true KR960001819B1 (en) 1996-02-05

Family

ID=26225146

Family Applications (1)

Application Number Title Priority Date Filing Date
KR87701159A KR960001819B1 (en) 1986-04-08 1987-12-08 Viral vector coding for a glycoprotein of the virus responsible

Country Status (12)

Country Link
EP (1) EP0245136B1 (ko)
JP (3) JP2719917B2 (ko)
KR (1) KR960001819B1 (ko)
AT (1) ATE103328T1 (ko)
AU (1) AU604696B2 (ko)
CA (1) CA1341353C (ko)
DE (1) DE3789400T2 (ko)
DK (1) DK175613B1 (ko)
ES (1) ES2052589T3 (ko)
FR (1) FR2606029B2 (ko)
PT (1) PT84640B (ko)
WO (1) WO1987006260A1 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681713A (en) * 1987-05-08 1997-10-28 Smithkline Beecham Corporation Expression of heterologous proteins in Drosophila cells
US6133029A (en) * 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
AU3775789A (en) * 1988-06-10 1990-01-05 Applied Biotechnology, Inc. A method of evaluating recombinant vaccines against immunodeficiency virus
ATE108335T1 (de) * 1989-03-03 1994-07-15 Microgenesys Inc Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
EP0897987B1 (en) * 1989-10-24 2001-02-28 Chiron Corporation Secretion of human protein linked to gamma interferon signal peptide
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
FR2766091A1 (fr) * 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
CA2531773A1 (en) 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
CN104870477B (zh) 2012-10-23 2018-10-09 爱默蕾大学 Gm-csf和il-4轭合物、组合物以及与其相关的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA867281B (en) * 1985-09-25 1987-05-27 Oncogen Vaccines and immunoassays for acquired immune deficiency syndrome
EP0243029A1 (en) * 1986-04-08 1987-10-28 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Recombinant vaccinia virus expressing human retrovirus gene

Also Published As

Publication number Publication date
FR2606029A2 (fr) 1988-05-06
EP0245136B1 (fr) 1994-03-23
DK175613B1 (da) 2004-12-27
JP2719917B2 (ja) 1998-02-25
CA1341353C (fr) 2002-04-02
EP0245136A1 (fr) 1987-11-11
AU7234987A (en) 1987-11-09
FR2606029B2 (fr) 1989-02-03
JPH08224090A (ja) 1996-09-03
PT84640A (fr) 1987-05-01
DK641787A (da) 1987-12-07
JPH1059868A (ja) 1998-03-03
ATE103328T1 (de) 1994-04-15
KR880701283A (ko) 1988-07-26
AU604696B2 (en) 1991-01-03
WO1987006260A1 (fr) 1987-10-22
JP2743164B2 (ja) 1998-04-22
DE3789400T2 (de) 1994-09-01
ES2052589T3 (es) 1994-07-16
JPH01500161A (ja) 1989-01-26
DK641787D0 (da) 1987-12-07
PT84640B (pt) 1989-11-30
DE3789400D1 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
KR960001819B1 (en) Viral vector coding for a glycoprotein of the virus responsible
CZ63995A3 (en) Virus vectors and their use in gene therapy
AU3636189A (en) Hiv-2 virus variants
WO1994023048A3 (en) Gibbon ape leukemia virus-based retroviral vectors
DK0842279T3 (da) Hjælpevirus til fremstilling af rekombinante virusvektorer
AU4233585A (en) Vaccine against rabies and preparation process thereof
AU7514087A (en) Vaccine containing the protein f of the aids virus
AU7028998A (en) Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
MX9707910A (es) Vector viral recombinante inducible por la glucosa.
WO1999020742A3 (en) A packaging cell line producing siv-pseudotyped mlv
DK631387D0 (da) Virusvektor
AU635309B2 (en) Gibbon ape leukemia virus receptor
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000208

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee